http://ijpba.in/index.php/ijpba/issue/feed International Journal of Pharmaceutical and Biological Science Archive 2019-03-09T04:54:33+00:00 A Gupta editor@ijpba.in Open Journal Systems <p>&nbsp;</p> <p>&nbsp;</p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><span style="color: blue; text-align: justify;"><span style="color: #000000;"><span style="box-sizing: inherit;"><strong style="box-sizing: inherit;"><span style="box-sizing: inherit;">International Journal of Pharmaceutical and Biological Science Archive (IJPBA)</span></strong></span><strong style="color: #009999; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 11.2px;">&nbsp;</strong></span></span><span style="color: #000000;"><span style="text-align: justify;"><strong style="box-sizing: inherit;"><span style="box-sizing: inherit;">(</span></strong></span><span style="text-align: justify;">ISSN 2349-2678)&nbsp;</span></span><span style="text-align: justify;">is a peer-reviewed bi-monthly journal dedicated to the publication of research papers, reviews, mini-reviews, Short</span><span style="text-align: justify; z-index: 2147483647;">&nbsp;communications&nbsp;</span><span style="text-align: justify;">and case studies. This publication is aimed at a broad, interdisciplinary audience of academic and industrial researchers actively engaged in basic and applied laboratory practice, related to Pharmaceutical Science and Therapeutics.</span></span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Physiotherapeutic Rehabilitation and Medical Science || Dentistry || Ayurveda&nbsp;|| Homeopathy&nbsp;||&nbsp;</strong></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Anatomy, Physiology, Biochemistry, Molecular Biology, Cell biology, Genetics, Hematology, Pathology, Immunology, Microbiology, Virology, Parasitology, Surgery, Dental Sciences, Sports Physiology,&nbsp;Histopathology, Toxicology and all major disciplines of Biomedical Sciences.</span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Pharmaceutical Sciences || Allied Sciences&nbsp;</strong></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology and Toxicology, Pharmaceutical and Biomedical Analysis, Clinical Research, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology and all major disciplines of Pharmaceutical&nbsp; Sciences.</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Articles are published as they are accepted and are freely available on the journal’s website to facilitate rapid and broad dissemination of research findings to a global audience.</span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Top Reasons for publication with us</strong></span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Quick Quality Review:</strong>&nbsp;The journal has strong international team of editors and reviewers, Rapid Decision and Publication</span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Very Low Publication Fees:</strong>&nbsp;Comparable journals charge a huge sum for each accepted manuscript. JPBR only charge the fees necessary to recoup cost associated with running the journal</span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Other features:</strong>&nbsp;DIDS Assigned and Implemented the Open Review System (ORS).</span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Important Notice:</strong></span></span></p> <hr> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Author can now directly send their manuscript as an email attachment to&nbsp;<strong style="font-size: 14px; font-family: 'lucida sans unicode', 'lucida grande', sans-serif;">||&nbsp;&nbsp;<span style="color: #0000ff;">editor@ijpba.in</span>&nbsp; || <span style="color: #0000ff;">editorijpba.in@gmail.com</span>&nbsp; || Call: <span style="color: #008000;">+91-9680566708&nbsp; </span>||</strong></span></span></p> <hr> <p>&nbsp;</p> http://ijpba.in/index.php/ijpba/article/view/108 CYBERKNIFE ROBOTIC RADIOSURGERY SYSTEM 2019-03-09T04:54:33+00:00 Saibya Gupta editor@innovativelibrary.info Priya Gupta editor@innovativelibrary.info <p>The latest addition to the CyberKnife product family, which was released in September 2009. This review updates the previous technical reviews of the original system version published in the late 1990s. There is a clear dose response for localized prostate cancer radiotherapy and there probablyis a radiobiological rationale for hypo-fractionation. Combining the two should maximize tumor control and increase the therapeutic ratio. Technical developments over the last decade have impacted virtually every aspect of the CyberKnife System. These developments have increased the geometric accuracy of the system and have enhanced the dosimetric accuracy and quality of treatment, with advanced inverse treatment planning algorithms, rapid Monte Carlo dose calculation, and post-processing tools that allow trade-offs between treatment efficiency and dosimetric quality to be explored. The CyberKnife can produce superior DVHs for sparing of rectum and bladder and excellent DVHs for target coverage compared with IMRT, and possesses dose heterogeneities to the same degree as IMRT plans.</p> <p><strong>Keywords:</strong> CyberKnife System; Radiosurgery; Stereotactic Body Radiation Therapy; Hypofractionation; IMRT Hetrogeneities</p> 2019-03-09T00:00:00+00:00 ##submission.copyrightStatement##